Amgen Inc
(NAS:AMGN)
$
393.1
+16.84 (+4.48%)
Market Cap: 212.16 Bil
Enterprise Value: 257.44 Bil
PE Ratio: 27.36
PB Ratio: 23.08
GF Score: 80/100 
Amgen Inc at Wells Fargo Healthcare Conference Transcript
Sep 08, 2022 / 01:45PM GMT
Release Date Price:
$245.45
(+0.27%)
Mohit Bansal
Wells Fargo Securities, LLC, Research Division - Senior Equity Analyst
Great. Thank you very much for joining us today. Good morning. My name is Mohit Bansal. I'm one of the biopharma analyst here at Wells Fargo. And I have great pleasure of having Amgen management team here. So with us, we have Peter Griffith from -- CFO of the company; and Dr. Dave Reese, EVP and Head of R&D of the company. Thank you very much for joining us today.
Peter H. Griffith
Amgen Inc. - Executive VP & CFO
Great to be with you, Mohit. Thank you, and thank you, Wells Fargo.
David M. Reese
Amgen Inc. - EVP of Research & Development
Thanks for having us.
Mohit Bansal
Wells Fargo Securities, LLC, Research Division - Senior Equity Analyst
Thank you. So maybe Peter, I'll just turn it over to you if you want to make a brief statement and then we'll go right into Q&A.
Peter H. Griffith
Amgen Inc. - Executive VP & CFO
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers